Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: Selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1β, tumor necrosis factor- α, and basic fibroblast growth factor

Journal of Rheumatology

Volumn 26, Issue 3, 1999, Pages 645-653

  Alsalameh, Saifeddin ^a,b,d   Mattka, Bärbel ^b   Al Ward, Rayya ^a   Lorenz, Hanns Martin ^a   Manger, Bernhard ^a   Pfizenmaier, Klaus ^c   Grell, Matthias ^c   Kalden, Joachim R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF STUTTGART   (Germany)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Articular cartilage; Cytokines; Growth factors; Joint destruction; Regulation of TNF receptors

Indexed keywords

MESSENGER RNA; RECEPTOR ANTIBODY; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANTIGENS, CD; CARTILAGE, ARTICULAR; CHONDROCYTES; DNA PRIMERS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-1; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0033015323     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Aggarwal BB, Natarajan K. Tumor necrosis factors: Developments during the last decade. Eur Cytokine Netw 1996;7:93-124.
2. Porteu F, Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem 1994;269:2834-40.
3. Schall TJ, Lewis M, Koller KJ, et al. Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 1990;61:361-70.
4. Gray PW, Barrett K, Chantry D, Turner M, Feldmann M. Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proc Natl Acad Sci USA 1990;87:7380-4.
5. Smith CA, Davis T. Anderson D, et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-23.
6. Brockhaus M, Schoenfeld H-J, Schlaeger E-J, Hunziker W, Lasslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 1990;87:3127-31.
7. Lewis M, Tartaglia LA, Lee A, et al. Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci USA 1991;88:2830-4.
8. Thoma B, Grell M, Pfizenmaier K, Scheurich P. Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 1990;172:1019-23.
9. Shalaby MR, Sundan A, Loetscher H, Brockhaus M, Lesslauer W, Espevik T. Binding and regulation of cellular functions by monoclonal antibodies against human tumor necrosis factor receptors. J Exp Med 1990;172:1517-20.
10. Engelmann H, Holtmann H, Brakebusch C, et al. Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem 1990;265:14497-504.
11. Makhay F, Loetscher H, Stueber D, Gehr G, Lesslauer W. Tumor necrosis factor α (TNF-α) induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med 1993;177:1277-86.
12. Brakebusch C, Nophar Y, Kemper O, Engelmann H, Wallach D. Cytoplasmic truncation of the p55 tumor necrosis factor receptor abolishes signalling, but not induced shedding of the receptor. EMBO J 1992;11:943-50.
13. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA, Goeddel DV. The two different recptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sci USA 1991;88:9292-6.
14. Grell M, Zimmermann G, Hülser D, Pfizenmaier K, Scheurich P. TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol 1994;153:1963-72.
15. Grell M, Scheurich P, Meager A, Pfizenmaier K. TR60 and TR80 tumor necrosis factor-receptors can independently mediate cytolysis. Lymphokine Cytokine Res 1993;12:143-8.
16. Dembic Z, Loetscher H, Gubler U, et al. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 1990;2:231-7.
17. Fiers W. Tumor necrosis factor: characterization at the molecular, cellular and in vivo level [letter]. FEBS 1991;285:199-212.
18. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNF-α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-9.
19. Cooper WO, Fava RA, Gates CA, Cremer MA, Townes AS. Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumor necrosis factor or transforming growth factor-beta. Clin Exp Immunol 1992;89:244-50.
20. Maini RN, Brennan FM, Williams R, et al. TNF-α in rheumatoid arthritis and prospects of anti-TNF therapy. Clin Exp Rheumatol II 1993;8:173-5.
21. Heilig B, Pezzutto A, Lukoschek M, Hunstein W. Expression of TNF receptors in rheumatoid arthritis and ankylosing spondylitis. Z Rheumatol 1993;52:383-9.
22. Adolf RA, Grell M, Scheurich P. Tumor necrosis factor. In: Luger TA, Schwarz T, editors. Epidermal growth factors and cytokines. New York: Marcel Dekker; 1994:63.
23. Keffer J, Probert L, Cazlaris H, et al. Transgenic mice expressing human tumor necrosis factor: a predicted genetic model of arthritis. EMBO J 1991;10:4025-31.
24. Georgopoulos S, Plows D, Kollias G. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 1996;46:86-9.
25. Elliott MJ, Maini RN, Feldmann M, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-27.
26. Maini RN, Elliot MJ, Brennan FM, Feldmann M. Beneficial effects of tumour necrosis factor alpha blockage in rheumatoid arthritis. Clin Exp Immunol 1995;101:207-12.
27. Neidel J, Schulze M, Lindschau J. Association between degree of bone erosion and synovial fluid levels of tumor necrosis factor alpha in the knee joints of patients with rheumatoid arthritis [review]. Inflamm Res 1995;44:217-21.
28. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor-α in rheumatoid arthritis. Arthritis Rheum 1995;38:151-9.
29. Lefebvre V, Peeters-Joris Ch, Vaes G. Modulation by interleukin-1 and tumor necrosis factor-α of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1990;1052:366-78.
30. Campbell IK, Piccoli DS, Roberts MJ, Muirden KD, Hamilton JA. Effects of tumor necrosis factor α and ß on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes. Arthritis Rheum 1990;33:542-52.
31. Campbell IK, Wojta J, Novak U, Hamilton JA. Cytokine modulation of plasminogen activator inhibitor-1 production by articular cartilage and chondrocytes. Down-regulation by tumor necrosis factor alpha and up-regulation by transforming growth factor-ß and basic fibroblast growth factor. Biochim Biophys Acta 1994;1226:277-85.
32. Bertolini DR, Nedwin GE, Bringman TS, Smith DE, Mundy GR. Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factor. Nature 1986;319:516-8.
33. Saklatvala J. Tumour necrosis factor a stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
34. Dinarello CA. Interleukin-1 and its biologically related cytokines. Adv Immunol 1989;44:153-205.
35. Malfait AM, Verbruggen G, Veys EM, Lambert J, De-Ridder L, Cornelissen M. Comparative and combined effects of interleukin 6, interleukin-1ß, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose. J Rheumatol 1994;21:314-320.
36. Alsalameh S, Kalden JR, Burmester GR. The role of cytokines and growth factors in the rheumatoid joint destruction. Z Rheumatol 1991;50:347-59.
37. Gamble JR, Harlan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA 1985;82:8667-71.
38. Shalaby MR, Aggarwal BB, Rinderknecht E, Svedersky LP, Finkle BS, Palladino MA. Activation of human polymorphonuclear neutrophil function by interferon gamma and tumor necrosis factor. J Immunol 1985;135:2069-73.
39. Dayer J-M, Beutler B, Cerami A. Cachectin/tumour necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
40. Alvaro-Gracia JM, Zvaifler NJ, Brown CB, Kaushansky K, Firestein GS. Cytokines in chronic inflammatory arthritis. VI. Analysis of the synovial cells involved in granulocyte-macrophage colony-stimulating factor and gene expression in rheumatoid arthritis and its regulation by IL-1 and tumor-necrosis factor-α. J Immunol 1991;146:3365-71.
41. Alsalameh S. Firestein GS, Oez S, Kurrle R, Kalden JR, Burmester GR. Regulation of granulocyte macrophage colony stimulating factor by human articular chondrocytes. Induction by both tumor necrosis factor-α and interleukin 1, down-regulation by transforming growth factor ß and up-regulation by fibroblast growth factor. J Rheumatol 1994;21:993-1002.
42. Sakurai H, Kohsaka H, Liu MF, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory anthritides. J Clin Invest 1995;96:2357-63.
43. Deleuran BW, Chu C, Field M, et al. Localization of tumor necrosis factor receptors in the synovial tissue and cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35:1170-8.
44. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992;31:653-61.
45. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
46. Lagoo-Deenadayalan S, Lagoo AS, Barber H, Hardy KJ. A standardized approach to PCR-based semiquantification of multiple cytokine gene transcripts from small cell samples. Lymphokine Res 1993;12:59-67.
47. Ju J, Ruan C, Fuller CW, Glazer AN, Mathies RA. Fluorescence energy transfer dye-labeled primers for DNA sequencing and analysis. Proc Natl Acad Sci USA 1995;92:4347-51.
48. Olliverre F. Gubler U, Towle CA, Laurencin C, Treadwell BV. Expression of IL-1 genes in human and bovine chondrocytes. A mechanism for autocrine control of cartilage degradation. Biochem Biophys Res Comm 1986;141:904-11.
49. Guerne PA, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990; 144:499-505.
50. Lotz M, Terkeltaub R, Villiger PM. Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J Immunol 1992;148:466-73.
51. Westacott CI, Atkins RM, Dieppe PA, Elson CJ. Tumor necrosis factor-α receptor expression on chondrocytes isolated from human articular cartilage. J Rheumatol 1994;21:1710-5.
52. Winzen R, Wallach D, Kemper O, Resch K, Holtmann H. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J Immunol 1993;150:4346-53.
53. Tartaglia LA, Pennica D, Goeddel DV. Ligand passing: the 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J Biol Chem 1993;268B: 18542-8.
54. Vandenabeele P, Leclercq W, Vanhaesebroeck B, Grooten J, Fiers W. Both TNF receptors are required for TNF-mediated induction apoptosis in PC60 cells. J Immunol 1995;154:2904-13.
55. Heller RA, Song K, Onasch MA, Fischer WH, Chang D, Ringold GM. A second tumor necrosis factor receptor gene product can shed a naturally occuring tumor necrosis factor inhibitor. Proc Natl Acad Sci USA 1990;87:6151-5.
56. Nophar Y, Kemper O, Brakebusch C, et al. Soluble forms of tumor necrosis factor receptors (TNF-R). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor. EMBO J 1990;9:3269-78.
57. Peetre C, Thysell H, Grubb A, Olsson I. A tumor necrosis factor binding protein is present in human biological fluids. Eur J Haematol 1988;41:414-9.
58. Cope AC, Anderka D, Doherty M, et al. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum 1992;35:1160-7.
59. Roux-Lombard P, Punzi L, Hasler F, et al. Soluble tumor necrosis factor receptors in human inflammatory synovial fluids. Arthritis Rheum 1993;36:485-9.
60. Grell M, Douni E, Wajat H, et al. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80-kD tumor necrosis receptor. Cell 1995;83:793-802.